Conditions: Breast Neoplasms
Keywords: Breast Cancer Metastatic Platelet
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 48
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine the effects of Plavix and aspirin in women with metastatic breast cancer.

Detailed description:

Arms:
arm 1: Patients will receive a 300 mg loading dose of Plavix on day 1, followed by 75 mg/day, and aspirin 81 mg per day starting day 1. Treatment will be continued until the treating physician elects to resume systemic therapy for the treatment of breast cancer or until unacceptable toxicity is observed. A pill diary will be collected monthly to monitor patients' compliance with the medication regimen. arm 2: Observation by treating physician

Interventions: intervention 1: Plavix intervention 2: Aspirin
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: